
1. mol biochem parasitol. 2018 jun;222:21-28. doi: 10.1016/j.molbiopara.2018.04.003.
epub 2018 apr 21.

a cas9 transgenic plasmodium yoelii parasite efficient gene editing.

qian p(1), wang x(1), yang z(1), li z(1), gao h(1), su xz(2), cui h(3), yuan
j(4).

author information: 
(1)state key laboratory cellular stress biology, innovation center cell
signal network, school life sciences, xiamen university, xiamen, fujian
361102, china.
(2)laboratory malaria vector research, national institute allergy and
infectious diseases, national institutes health, bethesda, md, 20892, united
states.
(3)state key laboratory cellular stress biology, innovation center cell
signal network, school life sciences, xiamen university, xiamen, fujian
361102, china. electronic address: cuihuiting@xmu.edu.cn.
(4)state key laboratory cellular stress biology, innovation center cell
signal network, school life sciences, xiamen university, xiamen, fujian
361102, china. electronic address: yuanjing@xmu.edu.cn.

the rna-guided endonuclease cas9 applied efficient gene-editing method 
in malaria parasite plasmodium. however, size (4.2 kb) commonly used
cas9 streptococcus pyogenes (spcas9) limits utility genome editing
in parasites introduced cas9 plasmid. establish endogenous
and constitutive expression cas9 protein rodent malaria parasite p.
yoelii, replaced coding region endogenous gene sera1 intact
spcas9 coding sequence using crispr/cas9-mediated genome editing method,
generating cas9-knockin parasite (pycas9ki) rodent malaria parasite p.
yoelii. resulted pycas9ki parasite displays normal progression the
whole life cycle possesses cas9 protein expression asexual blood
stage. introducing plasmid (pycs) containing sgrna homologous
template elements, successfully achieved deletion tagging
modifications different endogenous genes genome pycas9ki parasite. 
this cas9-knockin pycas9ki parasite provides new platform facilitating gene
functions study rodent malaria parasite p. yoelii.

copyright © 2018 elsevier b.v. rights reserved.

doi: 10.1016/j.molbiopara.2018.04.003 
pmid: 29684399  [indexed medline]

